FUTURE 3 Study Extension

Update Il y a 4 ans
Reference: NCT01338415

Woman and Man

Extract

The objectives of the FUTURE 3 Study Extension are to evaluate the long-term safety, tolerability and efficacy of the pediatric formulation of bosentan two versus three times a day in children with Pulmonary Arterial Hypertension (PAH).


Inclusion criteria

  • pulmonary arterial hypertension


Links